P/E ratio for Bio-Techne (TECH)
P/E ratio as of September 2023 (TTM): 38.1
According to Bio-Techne's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 38.1044. At the end of 2021 the company had a P/E ratio of 385.
P/E ratio history for Bio-Techne from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 385 | 38.09% |
| 2020 | 279 | 62.43% |
| 2019 | 171 | -24.75% |
| 2018 | 228 | 34.58% |
| 2017 | 169 | -13.13% |
| 2016 | 195 | 44.58% |
| 2015 | 135 | 14.55% |
| 2014 | 118 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 34.2 | -10.36% | 🇺🇸 USA |
 Becton Dickinson BDX | 47.8 | 25.40% | 🇺🇸 USA |
 General Electric GE | 13.7 | -63.96% | 🇺🇸 USA |
 Danaher DHR | 28.8 | -24.38% | 🇺🇸 USA |
 Qiagen QGEN | 26.7 | -29.82% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | -1.46 | -103.82% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -23.7 | -162.22% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.